These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 16735866)

  • 1. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series.
    Rao N; Regalla DM
    Clin Orthop Relat Res; 2006 Oct; 451():34-7. PubMed ID: 16735866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention.
    Moran E; Masters S; Berendt AR; McLardy-Smith P; Byren I; Atkins BL
    J Infect; 2007 Jul; 55(1):1-7. PubMed ID: 17343916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.
    Barberán J; Aguilar L; Carroquino G; Giménez MJ; Sánchez B; Martínez D; Prieto J
    Am J Med; 2006 Nov; 119(11):993.e7-10. PubMed ID: 17071171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
    Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis.
    Durante-Mangoni E; Casillo R; Bernardo M; Caianiello C; Mattucci I; Pinto D; Agrusta F; Caprioli R; Albisinni R; Ragone E; Utili R
    Clin Infect Dis; 2012 Feb; 54(3):347-54. PubMed ID: 22100575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
    Martone WJ; Lamp KC
    Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
    Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
    Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
    Segreti JA; Crank CW; Finney MS
    Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections.
    Stone PA; Armstrong PA; Bandyk DF; Brumberg RS; Flaherty SK; Back MR; Johnson BL; Shames ML
    J Vasc Surg; 2006 Oct; 44(4):757-61. PubMed ID: 17012000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
    Rao N; Hamilton CW
    Diagn Microbiol Infect Dis; 2007 Oct; 59(2):173-9. PubMed ID: 17574788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
    Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML
    J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections.
    Corona Pérez-Cardona PS; Barro Ojeda V; Rodriguez Pardo D; Pigrau Serrallach C; Guerra Farfán E; Amat Mateu C; Flores Sanchez X
    J Antimicrob Chemother; 2012 Jul; 67(7):1749-54. PubMed ID: 22511636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.
    Lalani T; Boucher HW; Cosgrove SE; Fowler VG; Kanafani ZA; Vigliani GA; Campion M; Abrutyn E; Levine DP; Price CS; Rehm SJ; Corey GR; Karchmer AW;
    J Antimicrob Chemother; 2008 Jan; 61(1):177-82. PubMed ID: 17999973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
    Katz DE; Lindfield KC; Steenbergen JN; Benziger DP; Blackerby KJ; Knapp AG; Martone WJ
    Int J Clin Pract; 2008 Sep; 62(9):1455-64. PubMed ID: 18662172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
    Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
    Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
    French GL
    J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
    Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
    Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.